Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00624078 · ClinicalTrials.gov registry record · Phase 2
Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation
A Phase 2 study, sponsored by Instituto Bioclon S.A. de C.V..
- Completed
- Registry status
- Phase 2
- Development phase
- 1,426
- Enrollment target
NCT00624078: Completed Phase 2 study, sponsored by Instituto Bioclon S.A. de C.V..
NCT00624078 is a Phase 2 study that has completed, run by Instituto Bioclon S.A. de C.V.. The registered enrollment target is 1,426 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (972% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00624078, a Phase 2 study, has completed, sponsored by Instituto Bioclon S.A. de C.V..
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 1,426 participants
- Enrollment target
Study Summary
This treatment protocol will enable therapeutic use of Anascorp in the management of systemic manifestations of scorpion sting envenomation, in patients for whom antivenom would otherwise be unavailable. The working hypotheses are as follows: 1. The investigational antivenom is safe as treatment of scorpion sting envenomation. 2. The investigational antivenom is effective as treatment of scorpion sting envenomation.
Interventions
- DRUG Antivenin Centruroides (scorpion) F(ab)2 Anascorp™
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,426 participants |
| Start Date | 2005-05 |
| Est. Completion | 2010-09 |
| Phase | Phase 2 |
What the finished NCT00624078 record still lists
NCT00624078 is an interventional study that assigns participants to a tested intervention. Its 1,426 participants enrollment target places it among the larger protocols in the corpus, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (972% higher).
The record links to 0 conditions, and to 1 intervention - of which Antivenin Centruroides (scorpion) F(ab)2 Anascorp™ is the first listed.
NCT00624078 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00624078 about?
NCT00624078 is a clinical study titled "Treatment Protocol for Use of Anascorp™ in Patients With Scorpion Sting Envenomation". This treatment protocol will enable therapeutic use of Anascorp in the management of systemic manifestations of scorpion sting envenomation, in patients for whom antivenom would otherwise be unavailable. The working hypotheses are as follows: 1. The investigational antivenom is safe as treatment of...
What is the current status of trial NCT00624078?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 1,426 participants. The study started on 2005-05. Estimated completion is 2010-09.
What interventions are being tested in trial NCT00624078?
The interventions under investigation include: Antivenin Centruroides (scorpion) F(ab)2 Anascorp™ (DRUG).
Who is sponsoring clinical trial NCT00624078?
This trial is sponsored by Instituto Bioclon S.A. de C.V., which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00624078's enrollment target sits among peer trials
1,426 12th of 2000 higher than 1,989 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04754022 · 1,440 participants · NA
Transfusion Requirements in Younger Patients Undergoing Cardiac Surgery
- NCT04989790 · 1,440 participants · NA
Clinical Effectiveness of the "PICU Up!" Multifaceted Early Mobility Intervention for Critically Ill Children
- NCT06122246 · 1,440 participants · NA
PRESSURE CHECK: Find Your Path to Better Health
- NCT06324318 · 1,440 participants · Phase 2
Parenting in 2 Worlds Multisite Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia